跳到正文
原文
Endpoints News· @endpts · X·· 22 小时前AI 评分42
AI 导读

ARCH 和 Population Health,即 Metsera 背后的团队,正在推出一家新的睡眠障碍初创公司,围绕一款来自中国的药物打造。https://endpoints.news/arch-and-population-health-return-to-china-for-new-startup-somnivera-targeting-sleep/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=

正文

ARCH and Population Health, the team behind Metsera, are launching a new sleep disorder startup built around a drug from China. https://endpoints.news/arch-and-population-health-return-to-china-for-new-startup-somnivera-targeting-sleep/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=

来源:Endpoints News · x.com